A Study of Galunisertib on the Immune System in Participants With Cancer

Summary

The main purpose of this study is to learn more about how the study drug called galunisertib affects the immune system in participants with cancer. The study treatment is expected to last about six months for each participant, not including screening or follow-up.

Timeline

Start

2015-05

Primary completion

2016-08

Completion

2016-08

Drugs

Indications